Does SACITUZUMAB GOVITECAN Cause Off label use? 111 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 111 reports of Off label use have been filed in association with SACITUZUMAB GOVITECAN (TRODELVY). This represents 8.8% of all adverse event reports for SACITUZUMAB GOVITECAN.
111
Reports of Off label use with SACITUZUMAB GOVITECAN
8.8%
of all SACITUZUMAB GOVITECAN reports
25
Deaths
38
Hospitalizations
How Dangerous Is Off label use From SACITUZUMAB GOVITECAN?
Of the 111 reports, 25 (22.5%) resulted in death, 38 (34.2%) required hospitalization, and 4 (3.6%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SACITUZUMAB GOVITECAN. However, 111 reports have been filed with the FAERS database.
What Other Side Effects Does SACITUZUMAB GOVITECAN Cause?
Disease progression (389)
Diarrhoea (184)
Death (182)
Inappropriate schedule of product administration (147)
Neutropenia (128)
Fatigue (109)
Febrile neutropenia (92)
Asthenia (90)
Weight decreased (89)
Nausea (87)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which SACITUZUMAB GOVITECAN Alternatives Have Lower Off label use Risk?
SACITUZUMAB GOVITECAN vs SACITUZUMAB GOVITECAN-HZIY
SACITUZUMAB GOVITECAN vs SACROSIDASE
SACITUZUMAB GOVITECAN vs SACUBITRIL
SACITUZUMAB GOVITECAN vs SACUBITRIL\VALSARTAN
SACITUZUMAB GOVITECAN vs SAFINAMIDE